First Trust NYSE Arca Biotechnology Index Fund (FBT) |
| 246.74 -0.65 (-0.26%) 07-27 16:00 |
| Open: | 248.595 |
| High: | 250.71 |
| Low: | 246.74 |
| Volume: | 42,190 |
| Market Cap: | 1,536(M) |
| PE Ratio: | 30.4 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 301.58 |
| Resistance 1: | 258.20 |
| Pivot price: | 249.09 |
| Support 1: | 239.49 |
| Support 2: | 227.92 |
| 52w High: | 258.2 |
| 52w Low: | 161.3 |
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 27 Jul 2026
FBT outperforms IBB by focusing on smaller biot... - Pluang
Mon, 27 Jul 2026
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It - 24/7 Wall St.
Sat, 25 Jul 2026
FBT ETF Profile: Dividends, Returns (BIVA:FBT) - TradingView
Thu, 23 Jul 2026
Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT? - The Motley Fool
Thu, 23 Jul 2026
Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT? - The Globe and Mail
Tue, 21 Jul 2026
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT? - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
